Reine Allan

SEC CIK 1714023 · EDGAR

Buying vs selling by month open-market trades, last 24 months, all 2 companies

BoughtSold

Companies

Ticker	Company	Title	Holding	Bought	Sold	Trades	First	Last
PRME	Prime Medicine, Inc.	CEO, Dir	125.0K	$147.5K	—	1	2025-05-21	2025-05-21
FHTX	Foghorn Therapeutics Inc.	CFO	53.8K	—	—	1	2021-08-09	2021-08-09

#	Insider	Title	Bought	Sold
No open-market trades in the last year.

Reine Allan made no open-market trades at PRME in the last 12 months.

X	Filed	Traded	Ticker	Company	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2025-05-22	2025-05-21	PRME	Prime Medicine, Inc.	Reine Allan	CEO, Dir	P - Purchase	$1.18	+125.0K	125.0K	New	+$147.5K
D	2021-08-11	2021-08-09	FHTX	Foghorn Therapeutics Inc.	Reine Allan	CFO	M - OptEx	$3.72	+26.9K	53.8K	+100%	+$100.0K

Purchase Sale Sale after option exercise All abbreviations